Diagnosis of Severe Acute Respiratory Syndrome (SARS) by Detection of SARS Coronavirus Nucleocapsid Antibodies in an Antigen-Capturing Enzyme-Linked Immunosorbent Assay
Recombinant severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein was employed to establish an antigen-capturing enzyme-linked immunosorbent assay (ELISA). Antinucleocapsid protein antibodies could be detected in 68.4% of probable SARS patients 6 to 10 days after illness and in 8...
Guardat en:
| Publicat a: | J Clin Microbiol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2003
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC309018/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14662982/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.41.12.5781-5782.2003 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
